The management of locally advanced cervical cancer
Authors:
- Pushpa Naga ChPCPushpa Naga Ch
- Lavanya GurramLGLavanya Gurram
- Supriya ChopraSCSupriya Chopra
- Umesh MahantshettyUMUmesh Mahantshetty
- 1 September 2018
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 30 (5) , 323-329
Abstract
Purpose of review: Cervical cancer is still a major cause of morbidity and mortality among women worldwide. Surgery and chemoradiation are widely utilized treatments for cervical cancer. Despite the available standard treatment of choice, outcome is suboptimal among patients with LACC. It is vital to integrate the evidence generated from high-quality research work for effective management of these cases. This review intends to critically evaluate the latest evidence supporting the available treatment modalities and to provide a comprehensive overview of recent advances and ongoing research in the management of LACC. Recent findings: Research advances in imaging and radiotherapy technologies, incorporating imaging into brachytherapy planning, use of newer targeted agents, chemotherapy intensification and immunotherapy are some of the new therapeutic options that have been in the forefront of research to improve the outcome of patients with LACC. Summary: Advanced imaging modalities are increasingly being utilized to tailor treatments. Neoadjuvant chemotherapy followed by surgery does not improve outcomes in FIGO Stage IB2–IIB. Although cisplatin-based concurrent chemoradiation is the standard of care, more aggressive systemic therapies (neoadjuvant or adjuvant chemotherapy and chemoradiation) and use of newer agents, still remains investigational.Keywords
This publication has 47 references indexed in Scilit:
- A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancerBritish Journal of Cancer, 2013
- Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancerRadiotherapy and Oncology, 2011
- Primary therapy for early-stage cervical cancer: radical hysterectomy vs radiationAmerican Journal of Obstetrics and Gynecology, 2009
- Comparison of chemoradiation with radiation as postoperative adjuvant therapy in cervical cancer patients with intermediate-risk factorsEuropean Journal of Surgical Oncology, 2009
- Comparison between conventional surgery and radiotherapy for FIGO stage I–II cervical carcinoma: A retrospective Japanese studyGynecologic Oncology, 2005
- Neoadjuvant chemotherapy for locally advanced cervical cancerEuropean Journal of Cancer, 2003
- Concurrent Cisplatin-based Chemotherapy plus Radiotherapy for Cervical Cancer – a Meta-analysisClinical Oncology, 2002
- A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical CancerNew England Journal of Medicine, 1999
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997